home.social

#protac — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #protac, aggregated by home.social.

  1. PROTACs que degradan KRAS provocan regresión tumoral profunda y duradera en modelos de cáncer de pulmón, superando a inhibidores y resistencias (Cancer Research). aidoo.news/noticia/rvXBw2

    #Oncologia #PROTAC #Investigacion #Ciencia #España

  2. Amazing news that the first #PROTAC for targeted protein degradation has been approved by the FDA. Great to see an entirely new modality added to the therapeutic toolbox.

    news.yale.edu/2026/05/07/yale-

    Very curious to see, how the field of induced proximity will develop further into the future with so many additional exciting applications already shown in basic academic research. Curious, which other therapeutic areas will most profit from this development. (1/2)

  3. Amazing news that the first #PROTAC for targeted protein degradation has been approved by the FDA. Great to see an entirely new modality added to the therapeutic toolbox.

    news.yale.edu/2026/05/07/yale-

    Very curious to see, how the field of induced proximity will develop further into the future with so many additional exciting applications already shown in basic academic research. Curious, which other therapeutic areas will most profit from this development. (1/2)

  4. Amazing news that the first #PROTAC for targeted protein degradation has been approved by the FDA. Great to see an entirely new modality added to the therapeutic toolbox.

    news.yale.edu/2026/05/07/yale-

    Very curious to see, how the field of induced proximity will develop further into the future with so many additional exciting applications already shown in basic academic research. Curious, which other therapeutic areas will most profit from this development. (1/2)

  5. Amazing news that the first #PROTAC for targeted protein degradation has been approved by the FDA. Great to see an entirely new modality added to the therapeutic toolbox.

    news.yale.edu/2026/05/07/yale-

    Very curious to see, how the field of induced proximity will develop further into the future with so many additional exciting applications already shown in basic academic research. Curious, which other therapeutic areas will most profit from this development. (1/2)

  6. Amazing news that the first #PROTAC for targeted protein degradation has been approved by the FDA. Great to see an entirely new modality added to the therapeutic toolbox.

    news.yale.edu/2026/05/07/yale-

    Very curious to see, how the field of induced proximity will develop further into the future with so many additional exciting applications already shown in basic academic research. Curious, which other therapeutic areas will most profit from this development. (1/2)

  7. PKMYT1 is a promising target for #cancer #drug developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico #Medicine have now introduced a novel #PROTAC degrader based on their computational design of a novel inhibitor. This study was now published in #Nature Communications (2025):
    nature.com/articles/s41467-025

    #drugdesign #chemistry #MedicinalChemistry #research #science

  8. PKMYT1 is a promising target for developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico have now introduced a novel degrader based on their computational design of a novel inhibitor. This study was now published in Communications (2025):
    nature.com/articles/s41467-025

  9. PKMYT1 is a promising target for #cancer #drug developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico #Medicine have now introduced a novel #PROTAC degrader based on their computational design of a novel inhibitor. This study was now published in #Nature Communications (2025):
    nature.com/articles/s41467-025

    #drugdesign #chemistry #MedicinalChemistry #research #science

  10. PKMYT1 is a promising target for #cancer #drug developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico #Medicine have now introduced a novel #PROTAC degrader based on their computational design of a novel inhibitor. This study was now published in #Nature Communications (2025):
    nature.com/articles/s41467-025

    #drugdesign #chemistry #MedicinalChemistry #research #science

  11. PKMYT1 is a promising target for #cancer #drug developmenent. While some inhibitors such as RP-6036 are available for some time, researchers from InSilico #Medicine have now introduced a novel #PROTAC degrader based on their computational design of a novel inhibitor. This study was now published in #Nature Communications (2025):
    nature.com/articles/s41467-025

    #drugdesign #chemistry #MedicinalChemistry #research #science

  12. 🤖 Can AI help us predict and prevent off-target effects in PROTAC drug design?

    🔗 Predicting PROTAC off-target effects via warhead involvement levels in drug–target interactions using graph attention neural networks. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2025.10

    📚 CSBJ: csbj.org/

    #DrugDevelopment #StructuralBiology #ChemicalBiology #PROTAC #DrugDiscovery #Cheminformatics #Bioinformatics #PrecisionMedicine #TargetedProteinDegradation

  13. 🤖 Can AI help us predict and prevent off-target effects in PROTAC drug design?

    🔗 Predicting PROTAC off-target effects via warhead involvement levels in drug–target interactions using graph attention neural networks. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2025.10

    📚 CSBJ: csbj.org/

    #DrugDevelopment #StructuralBiology #ChemicalBiology #PROTAC #DrugDiscovery #Cheminformatics #Bioinformatics #PrecisionMedicine #TargetedProteinDegradation

  14. 🧩 The future of drug discovery may depend on how well we understand PROTAC-driven protein partnerships.

    🔗 Mapping the energy landscape of PROTAC-mediated protein-protein interactions. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2023.02

    📚 CSBJ: csbj.org/

    #StructuralBiology #PROTAC #DrugDiscovery #ComputationalBiology #ProteinEngineering #ProteinDegradation #Biopharma #MedicinalChemistry #TargetedTherapies #AIinBiotech #MolecularModeling

  15. 🧩 The future of drug discovery may depend on how well we understand PROTAC-driven protein partnerships.

    🔗 Mapping the energy landscape of PROTAC-mediated protein-protein interactions. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2023.02

    📚 CSBJ: csbj.org/

    #StructuralBiology #PROTAC #DrugDiscovery #ComputationalBiology #ProteinEngineering #ProteinDegradation #Biopharma #MedicinalChemistry #TargetedTherapies #AIinBiotech #MolecularModeling

  16. 🧩 The future of drug discovery may depend on how well we understand PROTAC-driven protein partnerships.

    🔗 Mapping the energy landscape of PROTAC-mediated protein-protein interactions. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2023.02

    📚 CSBJ: csbj.org/

    #StructuralBiology #PROTAC #DrugDiscovery #ComputationalBiology #ProteinEngineering #ProteinDegradation #Biopharma #MedicinalChemistry #TargetedTherapies #AIinBiotech #MolecularModeling

  17. 🧩 The future of drug discovery may depend on how well we understand PROTAC-driven protein partnerships.

    🔗 Mapping the energy landscape of PROTAC-mediated protein-protein interactions. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2023.02

    📚 CSBJ: csbj.org/

    #StructuralBiology #PROTAC #DrugDiscovery #ComputationalBiology #ProteinEngineering #ProteinDegradation #Biopharma #MedicinalChemistry #TargetedTherapies #AIinBiotech #MolecularModeling

  18. 🧩 The future of drug discovery may depend on how well we understand PROTAC-driven protein partnerships.

    🔗 Mapping the energy landscape of PROTAC-mediated protein-protein interactions. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2023.02

    📚 CSBJ: csbj.org/

    #StructuralBiology #PROTAC #DrugDiscovery #ComputationalBiology #ProteinEngineering #ProteinDegradation #Biopharma #MedicinalChemistry #TargetedTherapies #AIinBiotech #MolecularModeling

  19. Postdoctoral Fellow

    Ruijin Hospital

    The new Frontiers in Therapeutics Research Laboratory is an exciting opportunity to launch your career in translational research.

    See the full job description on jobRxiv: jobrxiv.org/job/ruijin-hospita


    jobrxiv.org/job/ruijin-hospita

  20. Postdoctoral Fellow

    Ruijin Hospital

    The new Frontiers in Therapeutics Research Laboratory is an exciting opportunity to launch your career in translational research.

    See the full job description on jobRxiv: jobrxiv.org/job/ruijin-hospita


    jobrxiv.org/job/ruijin-hospita

  21. Postdoctoral Fellow

    Ruijin Hospital

    The new Frontiers in Therapeutics Research Laboratory is an exciting opportunity to launch your career in translational research.

    See the full job description on jobRxiv: jobrxiv.org/job/ruijin-hospita


    jobrxiv.org/job/ruijin-hospita

  22. Postdoctoral Fellow

    Ruijin Hospital

    The new Frontiers in Therapeutics Research Laboratory is an exciting opportunity to launch your career in translational research.

    See the full job description on jobRxiv: jobrxiv.org/job/ruijin-hospita


    jobrxiv.org/job/ruijin-hospita

  23. Postdoctoral Fellow

    Ruijin Hospital

    The new Frontiers in Therapeutics Research Laboratory is an exciting opportunity to launch your career in translational research.

    See the full job description on jobRxiv: jobrxiv.org/job/ruijin-hospita


    jobrxiv.org/job/ruijin-hospita

  24. Postdoctoral Fellow

    Ruijin Hospital

    The new Frontiers in Therapeutics Research Laboratory is an exciting opportunity to launch your career in translational research.

    See the full job description on jobRxiv: jobrxiv.org/job/ruijin-hospita


    jobrxiv.org/job/ruijin-hospita